# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Breast Cancer

Cancer, Breast
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 31-40 of 2380 results.
COX Inhibition and Biomarkers During Neoadjuvant Chemoendocrine Therapy for ER+, HER2- Stage I-III Breast Cancer
Status: Recruiting
Last Changed: Aug 04, 2020
First Received: Jul 30, 2019
Disease(s): Breast Cancer, Estrogen Receptor-positive Breast Cancer
Intervention(s): Aspirin, Tamoxifen Pill, Doxorubicin, Cyclophosphamide, Paclitaxel
Locations: University of Virginia, Charlottesville, Virginia, United States
A Trial Evaluating the Efficacy of Metastasectomy in Patients With Oligo-Metastatic Breast Cancer(OMIT)
Status: Recruiting
Last Changed: Jun 04, 2020
First Received: Jun 04, 2020
Disease(s): Breast Cancer
Intervention(s): Metastasectomy for the metastatic sites
Locations: Fudan University Shanghai Cancer Center, Shanghai, China
Pembrolizumab And Tamoxifen Among Women With Advanced Hormone Receptor Positive Breast Cancer And Esr1 Mutation
Status: Not yet recruiting
Last Changed: Mar 18, 2019
First Received: Mar 18, 2019
Disease(s): Breast Cancer Female
Intervention(s): Pembrolizumab + Tamoxifen
Locations: Mediclinic City Hospital, Dubai, United Arab Emirates
An Initial Safety Study of Gedatolisib Plus PTK7-ADC for Metastatic Triple-negative Breast Cancer
Status: Recruiting
Last Changed: Feb 17, 2020
First Received: Aug 09, 2017
Disease(s): Triple Negative Breast Cancer, Metastatic Breast Cancer
Intervention(s): Gedatolisib, PTK7-ADC
Locations: IU Simon Cancer Center, Indianapolis, Indiana, United States
Predictive Clinical and Biological Parameters in Breast Cancer
Status: Recruiting
Last Changed: Sep 05, 2017
First Received: Jan 31, 2012
Disease(s): Breast Cancer
Intervention(s): molecular alteration
Locations: Institut Paoli Calmettes, Marseille, France
Hôpital Sainte-Musse, Toulon, France
Acupuncture for Hot Flashes in Hormone Receptor-Positive Breast Cancer, a Randomized Controlled Trial
Status: Recruiting
Last Changed: Feb 06, 2020
First Received: Dec 21, 2018
Disease(s): Breast Cancer
Intervention(s): Acupuncture, Usual Care
Locations: Dana Farber Cancer Institute, Boston, Massachusetts, United States
Simvastatin Plus Dual Anti-HER2 Therapy for Metastatic Breast Cancer
Status: Recruiting
Last Changed: Jul 17, 2020
First Received: Oct 27, 2017
Disease(s): Breast Cancer Stage IV
Intervention(s): Simvastatin 80mg
Locations: Baylor College of Medicine, Houston, Texas, United States
Harris Health System, Houston, Texas, United States
Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.
Status: Recruiting
Last Changed: Feb 11, 2020
First Received: Feb 11, 2020
Disease(s): Metastatic Breast Cancer
Intervention(s): Disulfiram, Vinorelbin, Cisplatin, Copper
Locations: National Cancer Institute, Bratislava, Slovakia
Neoadjuvant Chemotherapy With or Without Metformin in Early Breast Cancer.
Status: Recruiting
Last Changed: Jun 11, 2020
First Received: May 14, 2020
Disease(s): Breast Cancer
Intervention(s): Metformin, Placebo oral tablet
Locations: Mansoura University Cancer center, Mansoura, Egypt
Comparison of Single-Agent Carboplatin vs the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple-Negative Breast Cancer
Status: Recruiting
Last Changed: Jan 03, 2020
First Received: Aug 25, 2015
Disease(s): Breast Cancer
Intervention(s): Carboplatin, Everolimus
Locations: Mount Sinai Downtown, New York, New York, United States
Mount Sinai West, New York, New York, United States
Icahn School of Medicine at Mount Sinai, New York, New York, United States